Dapsone to delay symptoms in Creutzfeldt-Jakob disease

Lancet

Volumn 352, Issue 9126, 1998, Pages 456-

  Manuelidis, Laura ^a   Fritch, William ^a   Zaitsev, Igor ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DAPSONE; INDOMETACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SYMPTOM;

EID: 0032497163     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79191-1     Document Type: Article

References (5)

1. 1 Prusiner S. The prion diseases. Sci Am 1995; 272: 30-37.
2. 2 Manuelidis L, Fritch W, Xi YG. Evolution of a strain of CJD that induces BSE-like plaques. Science 1997; 277: 94-98.
3. 3 Manuelidis L. Vaccination with an attenuated CJD strain prevents expression of a virulent agent. Proc Natl Acad Sci USA 1998; 95: 2520-25.
4. 4 Bourinbaiar A, Lee-Huang S. The non-steroidal anti-inflammatory drug, indomethacin as an inhibitor of HIV replication. FEBS Lett 1995; 360: 85-88.
5. 5 Namba Y, Kawatsu K, Izumi S, Ueki A, Ikeda K. Neurofibrillary tangeles and senile plaques in brain of elderly leprosy patients. Lancet 1992; 340: 978.